DEPOT MEDROXYPROGESTERONE ACETATE (DMPA) ENHANCES SUSCEPTIBILITY AND INCREASES THE WINDOW OF VULNERABILITY TO HIV-1 IN HUMANIZED MICE

Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice

Abstract The progestin-based hormonal contraceptive Depot Medroxyprogesterone Acetate (DMPA) is widely used in sub-Saharan Africa, where Coffee / Espresso / Tea Machine Cleaners HIV-1 is endemic.Meta-analyses have shown that women using DMPA are 40% more likely than women not using hormonal contraceptives to acquire Human Immunodeficiency Virus (HI

read more